Sunway Healthcare Holding launched its initial public offering (IPO) prospectus on Friday, February 27, 2026. The group aims to raise up to 2.86 billion ringgit, approximately 736 million dollars. This move positions the company for the largest market debut in Malaysia since 2017. The offering consists of 1.97 billion shares priced at 1.45 ringgit each. The retail subscription window is officially open from today until March 5, 2026. Trading is expected to commence on the Main Market of Bursa Malaysia on March 18, 2026. Upon listing, the company’s market valuation is projected to reach 16.7 billion ringgit. This listing will increase the total market capitalization of the Sunway Group’s four listed units to over 70 billion ringgit. The IPO has secured backing from 20 cornerstone investors, including the Employees Provident Fund and JPMorgan Asset Management. Proceeds from the listing are earmarked for major infrastructure and clinical enhancements. Approximately 66.5 percent, or 554 million ringgit, will fund the expansion of existing hospitals over the next 36 months. Another 29.9 percent is allocated to the redemption of sukuk wakalah. Sunway Healthcare enters the market following a record financial performance. In 2025, the parent group reported a net profit of 1.3 billion ringgit, a 13 percent increase from the previous year. The healthcare division specifically saw a 44.7 percent jump in pre-tax profit to 96.9 million ringgit, fueled by rising patient volumes and higher bed occupancy. The timing of the IPO coincides with a broader push for larger listings in Malaysia. Bursa Malaysia is targeting a total IPO market capitalization of 28 billion ringgit for 2026. This follows a robust 2025 where 60 companies went public, raising 2.36 billion dollars. The regional healthcare outlook remains a primary driver for the expansion. Malaysia’s medical inflation is projected to reach 16 percent in 2026, the highest rate since 2021. This trend is attributed to an aging population, the adoption of advanced medical technologies, and a growing demand for private healthcare services. Sunway Healthcare currently operates 1,805 licensed beds as of early 2026. The group aims to double this capacity by 2032. It also maintains a 30 percent dividend payout policy, positioning itself as a high-conviction play for investors seeking both growth and recurring income in a defensive sector.